RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?

Despite the early promise of RNA therapeutics as a magic bullet to modulate aberrant signaling in cancer, this field remains a work-in-progress. Nevertheless, RNA therapeutics is now a reality for the treatment of viral diseases (COVID-19) and offers great promise for cancer. This review paper speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartorius, Kurt, Antwi, Samuel O., Chuturgoon, Anil, Roberts, Lewis R., Kramvis, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115561/
https://www.ncbi.nlm.nih.gov/pubmed/35600358
http://dx.doi.org/10.3389/fonc.2022.891812

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115561/
https://www.ncbi.nlm.nih.gov/pubmed/35600358
http://dx.doi.org/10.3389/fonc.2022.891812

Ejemplares similares